1-2 of 2
Marc PE André, MD
Close
Sort by
Journal Articles

Interim Analysis of the Randomized Eortc/Lysa/Fil Intergroup H10 Trial On Early PET-Scan Driven Treatment Adaptation in Stage I/II Hodgkin Lymphoma

Marc PE André, MD, Oumedaly Reman, MD, Massimo Federico, MD, Théodore Girinski, MD, Pauline Brice, MD, Ercole Brusamolino, MD, Christophe Ferme, MD, Richard vander Maazen, MD, Monica Bellei, Catherine Sebban, MD, Franck Morschhauser, MD, PhD, Elly Lugtenburg, MD, PhD, Aspasia Stamatoulas, MD, Catherine Fortpied, Msc, Michel Meignan, MD, PhD, Annibale Versari, MD, Martin Hutchings, MD, John Raemaekers, MD
Journal: Blood
Blood (2012) 120 (21): 549.
https://doi.org/10.1182/blood.V120.21.549.549
Published: 2012
Journal Articles

First Report On the H10 EORTC/GELA/IIL Randomized Intergroup Trial On Early FDG-PET Scan Guided Treatment Adaptation Versus Standard Combined Modality Treatment in Patients with Supra-Diaphragmatic Stage I/II Hodgkin's Lymphoma, for the Groupe d'Etude Des Lymphomes De l'Adulte (GELA), European Organisation for the Research and Treatment of Cancer (EORTC) Lymphoma Group and the Intergruppo Italiano Linfomi (IIL).

Marc PE André, MD, Oumédaly Reman, MD, Massimo Fédérico, MD, Pauline Brice, MD, Ercole Brusamolino, MD, Théodore Girinski, MD, Christophe Ferme, MD, Richard vander Maazen, MD, Monica Bellei, Catherine Sebban, MD, Franck Morschhauser, MD, PhD, Elly Lugtenburg, MD, Aspasia Stamatoullas, MD, Liliana Baila, MD, MSc, Catherine Fortpied, MSc, Michel Meignan, MD, John M. Raemaekers, MD, PhD
Journal: Blood
Blood (2009) 114 (22): 97.
https://doi.org/10.1182/blood.V114.22.97.97
Published: 2009